Dr Lutz Angerer > Hogan Lovells International LLP > Munich, Germany > Lawyer Profile

Hogan Lovells International LLP‘s industry expertise spans automotive, consumer goods, energy, finance, life sciences, real estate and healthcare. The team comprehensively assists DAX40 companies as well as large national and international corporations with global restructuring projects, financing and corporate aspects of transactions; furthermore, the group has extensive experience in corporate disputes, including out-of-court dispute resolution and joint venture conflicts, in which litigation, arbitration and employment lawyers Olaf Gärtner and Kim Lars Mehrbrey are particularly active. Volker Geyrhalter and Nikolas Zirngibl lead the corporate and M&A practice and have longstanding experience in transactions and restructuring projects. Lutz Angerer advises companies on stock corporation issues, corporate governance and compliance, while Michael Rose advises on public takeovers, restructurings and joint ventures. Joachim Habetha (corporate structuring, corporate succession, M&A) joined Schalast Law | Tax in January 2024.

Hogan Lovells International LLP is among the top players in the healthcare and life sciences sector and comprehensively advises on various topics with a focus on regulatory and contractual advice pertaining to future technologies in the life sciences sector, such as novel therapies and cell therapies – Jörg Schickert (co-head of the European regulatory team), Ina Brock (product liability), Arne Thiermann (regulatory, compliance) and Matthias Schweiger (litigation) frequently take the lead here. The team also covers issues at the interfaces with public law and contract law as well as IP, IT, data protection and product liability, thus advising on digital healthcare as well as strategic cooperations between pharmaceutical and IT companies. Schickert and Brock jointly head the practice with Andreas von Falck, who focuses on life sciences as well as the chemical and high-tech industries and represents clients in patent disputes, and Tanja Eisenblätter, who is particularly well versed in medical device and pharmaceutical advertising law. Lutz Angerer regularly advises large pharmaceutical companies and private equity houses on licensing and M&A transactions.